Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 58-62

  Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Inflammation; Joint; Mesenchymal stem cell; Regeneration; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; OSTEOPROTEGERIN; POLYGLACTIN; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 2; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; EXPERIMENTAL ANIMAL; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; JOINT DESTRUCTION; JOINT REPAIR; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TISSUE REPAIR; ANIMAL; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; DISEASE MODEL; JOINT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; TREATMENT OUTCOME;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROCYTES; DISEASE MODELS, ANIMAL; HUMANS; JOINTS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOBLASTS; OSTEOCLASTS; REGENERATION; REGENERATIVE MEDICINE; TREATMENT OUTCOME;

EID: 84953343483     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BURMESTER GR, KIVITZ AJ, KUPPER H et al.: Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial. Ann Rheum Dis 2015; 74: 1037-44.
2. FURST DE, EMERY P: Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford) 2014; 53: 1560-9.
3. McINNES IB, SCHETT G: The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
4. ALETAHA D, NEOGI T, SILMAN AJ et al.: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
5. SMOLEN JS, ALETAHA D, BIJLSMA JW et al.: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69: 631-7.
6. URBAN VS, KISS J, KOVACS J et al.: Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008; 26: 244-53.
7. da SILVA MEIRELLES L, CHAGASTELLES PC, NARDI NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-13.
8. HORWITZ EM, GODON PL, KOO WK et al.: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-7.
9. GUO CA, LIU XG, HUO JZ, JIANG C, WEN XJ, CHEN ZR: Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-beta1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng 2007; 103: 547-56.
10. le BLANC K, RASMUSSON I, SUNDBERG B et al.: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41.
11. SUN L, AKIYAMA K, ZHANG H et al.: Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009; 27: 1421-32.
12. GORMAN JD, SACK KE, DAVIS JC, Jr.: Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002; 346: 1349-56.
13. AUGELLO A, TASSO R, NEGRINI SM, CANCEDDA R, PENNESI G: Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56: 1175-86.
14. SONOMOTO K, YAMAOKA K, OSHITA K et al.: Interleukin-1beta induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. Arthritis Rheum 2012; 64: 3355-63.
15. FUKUYO S, YAMAOKA K, SONOMOTO K et al.: IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology (Oxford) 2014; 53: 1282-90.
16. DJOUAD F, BOUFFI C, GHANNAM S, NOEL D, JORGENSEN C: Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nature Rev Rheum 2009; 5: 392-9.
17. OSHITA K, YAMAOKA K, UDAGAWA N et al.: Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis Rheum 2011; 63: 1658-67.
18. DOWTHWAITE GP, BISHOP JC, REDMAN SN et al.: The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004; 117: 889-97.
19. ALSALAMEH S, AMIN R, GEMBA T, LOTZ M: Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004; 50: 1522-32.
20. PRETZEL D, LINSS S, ROCHLER S et al.: Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res Ther 2011; 13: R64.
21. KONDO M, YAMAOKA K, SONOMOTO K et al.: IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells. PloS one 2013; 8: e79463.
22. CHEN L, TREDGET EE, WU PY, WU Y: Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PloS one 2008; 3: e1886.
23. KONDO M, YAMAOKA K, SAKATA K et al.: Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells. Arthritis Rheum 2015; 67: 1250-60.
24. ROMBOUTS WJ, PLOEMACHER RE: Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003; 17: 160-70.
25. CHAMBERLAIN G, FOX J, ASHTON B, MIDDLETON J: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-49.
26. GONZALEZ MA, GONZALEZ-REY E, RICO L, BUSCHER D, DELGADO M: Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009; 60: 1006-19.
27. SMITH DM, SIMON JK, BAKER JR, Jr.: Applications of nanotechnology for immunology. Nat Rev Immunol 2013; 13: 592-605.
28. LU JM, WANG X, MARIN-MULLER C et al.: Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 2009; 9: 325-41.
29. OLIVARES-NAVARRETE R, HYZY SL et al.: Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. Biomaterials 2010; 31: 2728-35.
30. ZHANG X, YAMAOKA K, SONOMOTO K et al.: Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats. PloS one 2014; 9: e114621.